Mr. Marc Lemieux reports

KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.

KDA Group Inc. entered today, Nov. 25, 2025, into a share transfer agreement with ERxpert Inc. to acquire 20 per cent of the issued and outstanding shares of its subsidiary, Groupe Technologique KDA Inc., held by ERxpert.

ERxpert has agreed to transfer the transferred shares to KDA in exchange for 35 million common shares of KDA.

"The acquisition of the 20-per-cent minority interest in GTK marks an important strategic milestone for KDA. By consolidating our position, we strengthen our commitment to the development and commercialization of innovative technological solutions for health care professionals. This decision reflects our confidence in GTK's expertise and our determination to accelerate value creation for our partners and clients. We are convinced that this full integration will foster sustainable growth and a positive impact on the future of our corporation," said Marc Lemieux, chief executive officer and chairman of the board of KDA.

Yves Marmet is a minority shareholder, director and officer of ERxpert, and Marie-Helene Pinard is a minority shareholder of ERxpert. They are also officers of GTK. Mr. Marmet and Ms. Pinard do not control ERxpert and hold no shares of GTK.

No finders' fees are payable in connection with the transaction. KDA was the controlling shareholder of GTK, holding 80 per cent of its issued and outstanding shares, and now wholly owns this subsidiary. GTK specializes in the development and commercialization of technological solutions for health care professionals.

The transaction remains subject to approval by the TSX Venture Exchange. The issued shares will be issued to ERxpert pursuant to prospectus exemptions under securities laws, and will be subject to a four-month-and-one-day hold period from the date of issuance in accordance with securities regulations.

About KDA Group Inc.

KDA Group is a leader in technological innovations and specialized software solutions (software as a service) for the health care professional market. KDA is a corporation that offers high-quality products, and has recognized and respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate health care digital transformation, and are available for the Canadian and international markets.

We seek Safe Harbor.